#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	13378	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2036	651.4	0	.	n	.	0	C1450T	SNP	1450	1450	C	1669	1669	T	741	T	683	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	13378	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2036	651.4	1	SNP	n	C1184T	0	.	.	1184	1184	C	1403	1403	C	782	C	740	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	13378	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2036	651.4	0	HET	.	.	.	A266G	.	266	266	A	485	485	A	705	A,G	499,169	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24598	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3606	680.5	0	.	n	.	0	G1337A	SNP	1337	1337	G	1663	1663	A	764	A	719	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24598	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3606	680.5	0	.	n	.	0	T1971C	SNP	1971	1971	T	2297	2297	C	789	C	750	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24598	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3606	680.5	1	SNP	n	A2045G	0	.	.	2045	2045	A	2371	2371	A	828	A	783	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24598	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3606	680.5	1	SNP	n	C2597T	0	.	.	2597	2597	C	2923	2923	C	767	C,T	728,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
blaTEM.WHO_M_pConjugative_00003	blaTEM.WHO_M_pConjugative_00003	1	0	27	47096	blaTEM	861	861	100.0	blaTEM.l6.c30.ctg.1	1583	2965.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Betalactam resistance
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	2028	folP	855	855	99.88	folP.l15.c4.ctg.1	1634	123.8	1	SNP	p	R229S	1	.	.	685	687	AGC	1104	1106	AGC	194;194;195	A;G;C	184;180;181	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_G_01105	gyrA.WHO_G_01105	1	1	539	5178	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3366	153.4	0	.	p	.	0	D95A	NONSYN	283	285	GAC	580	582	GCC	163;160;160	G;C,G;C	155;148,1;149	.	.
gyrA.WHO_G_01105	gyrA.WHO_G_01105	1	1	539	5178	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3366	153.4	1	SNP	p	S91F	1	.	.	271	273	TTC	568	570	TTC	165;165;165	T,C;T;C	158,1;157;156	gyrA.WHO_G_01105:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	531	1530	mtrR	633	633	99.06	mtrR.l15.c4.ctg.1	1354	112.7	0	.	p	.	0	A39T	NONSYN	115	117	GCC	536	538	ACC	196;194;197	A,G;C;C	182,1;184;185	.	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	531	1530	mtrR	633	633	99.06	mtrR.l15.c4.ctg.1	1354	112.7	0	.	p	.	0	Y105H	NONSYN	313	315	TAC	734	736	CAC	191;194;195	C,A;A;C	180,1;179;185	.	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	531	1530	mtrR	633	633	99.06	mtrR.l15.c4.ctg.1	1354	112.7	0	.	p	.	0	A127fs	FSHIFT	379	379	G	800	800	G	193	G	183	.	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	531	1530	mtrR	633	633	99.06	mtrR.l15.c4.ctg.1	1354	112.7	1	SNP	p	G45D	0	.	.	133	135	GGC	554	556	GGC	199;198;200	G;G;C	183;182;185	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	864	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	937	91.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	4844	parC	2304	2304	99.87	parC.l6.c4.ctg.1	2867	167.8	0	.	p	.	0	I384V	NONSYN	1150	1152	ATC	1410	1412	GTC	195;196;196	G;T;C	182;181;184	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	4844	parC	2304	2304	99.87	parC.l6.c4.ctg.1	2867	167.8	1	SNP	p	D86N	0	.	.	256	258	GAC	516	518	GAC	210;210;207	G;A;C	199;197;196	parC.WHO_V_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	4844	parC	2304	2304	99.87	parC.l6.c4.ctg.1	2867	167.8	1	SNP	p	S87R	1	.	.	259	261	CGT	519	521	CGT	201;207;209	C,T;G;T	194,1;198;200	parC.WHO_V_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	4844	parC	2304	2304	99.87	parC.l6.c4.ctg.1	2867	167.8	1	SNP	p	R87I	0	.	.	259	261	CGT	519	521	CGT	201;207;209	C,T;G;T	194,1;198;200	parC.WHO_V_00204c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	4844	parC	2304	2304	99.87	parC.l6.c4.ctg.1	2867	167.8	1	SNP	p	R87W	0	.	.	259	261	CGT	519	521	CGT	201;207;209	C,T;G;T	194,1;198;200	parC.WHO_V_00204c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	4844	parC	2304	2304	99.87	parC.l6.c4.ctg.1	2867	167.8	1	SNP	p	S88P	0	.	.	262	264	TCC	522	524	TCC	208;207;207	T;C;C	199;197;198	parC.WHO_V_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4046	parE	1986	1986	99.95	parE.l15.c4.ctg.1	2692	149.8	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1547	1549	GGC	203;201;200	G;G;C	187;182;183	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.19.001	penA.19.001	1	1	27	3828	penA	1752	1752	100.0	penA.l6.c17.ctg.1	2392	159.4	1	SNP	p	A311V	0	.	.	931	933	GCA	1271	1273	GCA	204;203;204	G;C;A	191;191;198	penA.19.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3828	penA	1752	1752	100.0	penA.l6.c17.ctg.1	2392	159.4	1	SNP	p	I312M	0	.	.	934	936	ATC	1274	1276	ATC	208;204;202	A;T;C	196;195;191	penA.19.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3828	penA	1752	1752	100.0	penA.l6.c17.ctg.1	2392	159.4	1	SNP	p	V316T	0	.	.	946	948	GTG	1286	1288	GTG	202;204;203	G;T;G	195;197;197	penA.19.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3828	penA	1752	1752	100.0	penA.l6.c17.ctg.1	2392	159.4	1	SNP	p	V316P	0	.	.	946	948	GTG	1286	1288	GTG	202;204;203	G;T;G	195;197;197	penA.19.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3828	penA	1752	1752	100.0	penA.l6.c17.ctg.1	2392	159.4	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1790	1792	ACC	209;211;210	A,G;C;C,A,T	193,1;198;197,1,1	penA.19.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3828	penA	1752	1752	100.0	penA.l6.c17.ctg.1	2392	159.4	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1844	1846	GCG	199;202;206	G;C,G;G	175;162,1;175	penA.19.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3828	penA	1752	1752	100.0	penA.l6.c17.ctg.1	2392	159.4	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1844	1846	GCG	199;202;206	G;C,G;G	175;162,1;175	penA.19.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3828	penA	1752	1752	100.0	penA.l6.c17.ctg.1	2392	159.4	1	SNP	p	G543S	0	.	.	1627	1629	GGT	1967	1969	GGT	165;160;158	G;G;T	155;150;148	penA.19.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3828	penA	1752	1752	100.0	penA.l6.c17.ctg.1	2392	159.4	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1976	1978	GGC	158;159;162	G;G;C	146;149;149	penA.19.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3828	penA	1752	1752	100.0	penA.l6.c17.ctg.1	2392	159.4	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1994	1996	CCG	157;159;161	C,G;C;G	111,2;117;119	penA.19.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5394	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3091	173.8	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1646	1648	CCG	203;206;206	C;C;G	182;191;192	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2236	porA	1146	1146	99.65	porA.l15.c4.ctg.1	1838	121.1	0	.	p	.	0	M83fs	FSHIFT	247	247	A	541	541	C	161	C,T	141,1	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	256	porB1a	984	268	90.07	porB1a.l15.c30.ctg.2	567	14.8	0	.	p	.	0	H217N	NONSYN	649	651	CAT	324	326	AAT	13;13;13	A;A;T	13;13;13	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	256	porB1a	984	268	90.07	porB1a.l15.c30.ctg.2	567	14.8	0	.	p	.	0	D218N	NONSYN	652	654	GAT	327	329	AAT	12;12;12	A;A;T	12;12;12	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	256	porB1a	984	268	90.07	porB1a.l15.c30.ctg.2	567	14.8	0	.	p	.	0	V226A	NONSYN	676	678	GTA	351	353	GCA	13;13;13	G;C;A	13;13;13	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	256	porB1a	984	268	90.07	porB1a.l15.c30.ctg.2	567	14.8	0	.	p	.	0	.	MULTIPLE	700	702	ACT	374	376	GTA	12;12;12	G;T;A	12;12;12	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	256	porB1a	984	268	90.07	porB1a.l15.c30.ctg.2	567	14.8	0	.	p	.	0	S236N	NONSYN	706	708	AGC	380	382	AAC	12;12;12	A;A;C	12;12;12	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	256	porB1a	984	268	90.07	porB1a.l15.c30.ctg.2	567	14.8	0	.	p	.	0	.	MULTIPLE	709	711	AAC	384	388	TGGCG	11;11;13;16;18	T;G;G;C;G	11;11;13;16;18	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	256	porB1a	984	268	90.07	porB1a.l15.c30.ctg.2	567	14.8	0	.	p	.	0	D238A	NONSYN	712	714	GAT	390	392	GCT	19;19;21	G;C;T	19;19;21	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	256	porB1a	984	268	90.07	porB1a.l15.c30.ctg.2	567	14.8	0	.	p	.	0	V258L	NONSYN	772	774	GTA	450	452	TTA	32;34;34	T;T;A	29;31;31	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	256	porB1a	984	268	90.07	porB1a.l15.c30.ctg.2	567	14.8	0	.	p	.	0	Y273H	NONSYN	817	819	TAT	495	497	CAT	40;39;37	C;A;T	37;36;35	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	256	porB1a	984	268	90.07	porB1a.l15.c30.ctg.2	567	14.8	0	.	p	.	0	D274S	NONSYN	820	822	GAT	498	500	AGT	36;36;36	A;G;T	35;35;35	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	256	porB1a	984	268	90.07	porB1a.l15.c30.ctg.2	567	14.8	0	.	p	.	0	N277Y	NONSYN	829	831	AAC	507	509	TAC	36;36;36	T;A;C	35;35;35	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2576	porB1b	1035	1035	98.94	porB1b.l6.c4.ctg.1	1694	151.2	0	.	p	.	0	R143G	NONSYN	427	429	AGA	901	903	GGA	203;208;208	G;G;A	192;196;192	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2576	porB1b	1035	1035	98.94	porB1b.l6.c4.ctg.1	1694	151.2	0	.	p	.	0	.	INDELS	629	630	AA	1104	1106	TAG	222;221;219	T;A;G	208;210;207	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2576	porB1b	1035	1035	98.94	porB1b.l6.c4.ctg.1	1694	151.2	0	.	p	.	0	.	MULTIPLE	631	633	TAC	1108	1111	CAAT	220;219;217;222	C;A;A;T	204;207;207;209	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2576	porB1b	1035	1035	98.94	porB1b.l6.c4.ctg.1	1694	151.2	0	.	p	.	0	N212fs	FSHIFT	634	634	A	1113	1113	T	224	T	212	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2576	porB1b	1035	1035	98.94	porB1b.l6.c4.ctg.1	1694	151.2	1	SNP	p	G120K	0	.	.	358	360	GGT	832	834	GGT	190;190;191	G;G;T	180;178;176	porB1b.WHO_U_02278c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2576	porB1b	1035	1035	98.94	porB1b.l6.c4.ctg.1	1694	151.2	1	SNP	p	A121D	0	.	.	361	363	GCC	835	837	GCC	191;191;193	G;C;C	177;180;183	porB1b.WHO_U_02278c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2576	porB1b	1035	1035	98.94	porB1b.l6.c4.ctg.1	1694	151.2	1	SNP	p	A121N	0	.	.	361	363	GCC	835	837	GCC	191;191;193	G;C;C	177;180;183	porB1b.WHO_U_02278c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	539	9666	rpoB	4179	4179	99.98	rpoB.l6.c30.ctg.1	4996	193.1	1	SNP	p	H553N	1	H553N	NONSYN	1657	1659	CAT	2043	2045	AAT	173;175;176	A;A;T	164;167;165	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	984	rpsJ	312	312	100.0	rpsJ.l15.c30.ctg.1	1162	84.2	1	SNP	p	V57M	1	.	.	169	171	ATG	636	638	ATG	205;207;208	A,G;T;G	192,1;195;197	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10834	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2607	414.2	0	.	p	.	0	M177T	NONSYN	529	531	ATG	920	922	ACG	450;449;446	A;C;G,A	437;437;432,1	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10834	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2607	414.2	0	.	p	.	0	Y184D	NONSYN	550	552	TAC	941	943	GAC	388;391;391	G;A;C	386;382;390	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10834	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2607	414.2	0	.	p	.	0	T190M	NONSYN	568	570	ACG	959	961	ATG	371;369;371	A;T;G,T	371;367;370,1	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10834	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2607	414.2	0	.	p	.	0	L194S	NONSYN	580	582	TTA	971	973	TCA	374;375;372	T;CA,C;A	370;369,1;370	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10834	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2607	414.2	0	.	p	.	0	H209Q	NONSYN	625	627	CAT	1016	1018	CAG	385;388;383	C;A;G	381;385;379	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10834	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2607	414.2	0	.	p	.	0	V216L	NONSYN	646	648	GTT	1037	1039	CTT	373;377;374	C;T;T	371;375;371	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10834	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2607	414.2	0	.	p	.	0	N223S	NONSYN	667	669	AAC	1058	1060	AGT	383;392;394	A;G;T	375;379;377	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10834	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2607	414.2	0	.	p	.	0	Q246P	NONSYN	736	738	CAG	1127	1129	CCG	485;487;491	C;C;G	459;462;464	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10834	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2607	414.2	0	.	p	.	0	P280S	NONSYN	838	840	CCG	1229	1231	TCG	562;560;561	T;C;G	532;531;531	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10834	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2607	414.2	0	.	p	.	0	E337K	NONSYN	1009	1011	GAG	1400	1402	AAA	321;316;313	A;A;A	308;303;301	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10834	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2607	414.2	0	.	p	.	0	R338K	NONSYN	1012	1014	AGA	1403	1405	AAG	309;302;299	A;A;G	296;292;286	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10834	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2607	414.2	0	.	p	.	0	L343H	NONSYN	1027	1029	CTC	1418	1420	CAC	252;253;249	C;A;C	249;241;245	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10834	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2607	414.2	0	.	p	.	0	Q356E	NONSYN	1066	1068	CAA	1457	1459	GAA	269;268;267	G;A;A	269;267;265	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10834	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2607	414.2	0	.	p	.	0	A382T	NONSYN	1144	1146	GCG	1535	1537	ACG	180;179;175	A;C;G	178;176;172	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10834	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2607	414.2	0	.	p	.	0	T399I	NONSYN	1195	1197	ACT	1586	1588	ATT	251;251;250	A,T;T;T	239,1;240;240	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10834	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2607	414.2	0	.	p	.	0	C400S	NONSYN	1198	1200	TGT	1589	1591	AGT	251;255;252	A;G;T	238;241;239	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10834	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2607	414.2	0	.	p	.	0	I413L	NONSYN	1237	1239	ATA	1628	1630	CTA	264;266;275	C;T,C;A	246;247,1;259	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10834	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2607	414.2	0	.	p	.	0	K427N	NONSYN	1279	1281	AAA	1670	1672	AAT	202;201;203	A;A;T	195;194;197	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10834	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2607	414.2	0	.	p	.	0	A450S	NONSYN	1348	1350	GCA	1739	1741	TCA	268;272;276	T;C;A	254;256;259	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10834	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2607	414.2	0	.	p	.	0	V458M	NONSYN	1372	1374	GTA	1763	1765	ATG	284;286;288	A;T;G	274;276;278	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10834	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2607	414.2	0	.	p	.	0	N556T	NONSYN	1666	1668	AAC	2057	2059	ACC	618;622;621	A;C;C	570;583;578	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10834	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2607	414.2	0	.	p	.	0	K588E	NONSYN	1762	1764	AAA	2153	2155	GAA	612;610;605	G;A;A	585;584;580	.	Tetracycline resistance
